Maxcyte Inc (MXCT)

12:23 PM

Published on: 2025-07-23 21:52:41 - Autocar Professional

12:23 PM

10:49 AM

What drives MaxCyte Inc. stock priceFree Technical Analysis Support - Autocar Professional

10:49 AM

08:38 AM

What analysts say about MaxCyte Inc. stockFree Real-Time Stock Data - Autocar Professional

08:38 AM

04:56 AM

MaxCyte Inc. Stock Analysis and ForecastHigh-yield capital appreciation - jammulinksnews.com

04:56 AM

04:24 AM

Is MaxCyte Inc. a good long term investmentPhenomenal capital appreciation - Autocar Professional

04:24 AM

Jul 15, 2025

Why MaxCyte Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser

Jul 15, 2025

Jul 15, 2025

What makes MaxCyte Inc. stock price move sharplySwing Trade Signals - Newser

Jul 15, 2025

Jul 15, 2025

IWN ETF Implied Analyst Target Price: $198.15 - AInvest

Jul 15, 2025

Jul 15, 2025

How MaxCyte Inc. stock performs during market volatilityDaily Swing Candidates - Newser

Jul 15, 2025

Jul 09, 2025

MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times

Jul 09, 2025

Jul 09, 2025

MaxCyte, Inc. to Release Second Quarter 2025 Financial Results on August 6th - Nasdaq

Jul 09, 2025

Jul 02, 2025

PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan - BioSpectrum Asia

Jul 02, 2025

Jul 01, 2025

PHC TO EXCLUSIVELY DISTRIBUTE MAXCYTE CELL ENGINEERING PLATFORM IN JAPAN - bernama

Jul 01, 2025

Jul 01, 2025

Business Wire - JIJI PRESS

Jul 01, 2025

Jul 01, 2025

PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan - Business Wire

Jul 01, 2025

Jun 26, 2025

MaxCyte Cancels AIM Market Trading for Common Stock - TipRanks

Jun 26, 2025

Jun 25, 2025

MaxCyte shares trading for last time in London - Sharecast.com

Jun 25, 2025

Jun 23, 2025

Moving Gene Editing Advances Into the Clinic - the-scientist.com

Jun 23, 2025

Jun 19, 2025

MaxCyte stockholders approve AIM delisting, company to trade only on Nasdaq - Investing.com

Jun 19, 2025

Jun 18, 2025

MaxCyte Shareholders Approve Equity Plan Amendment - TipRanks

Jun 18, 2025

Jun 18, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting - Investing.com

Jun 18, 2025

Jun 18, 2025

Analyzing Ratios: MaxCyte Inc (MXCT)’s Financial Story Unveiled - DWinneX

Jun 18, 2025

Jun 18, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting By Investing.com - Investing.com UK

Jun 18, 2025

Jun 13, 2025

California State Teachers Retirement System Sells 82,134 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 13, 2025

Jun 12, 2025

MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks

Jun 12, 2025

Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing By Investing.com - Investing.com South Africa

Jun 11, 2025

Jun 11, 2025

MaxCyte & Ori Biotech Integrate Platforms for Efficient Manufacturing - Contract Pharma

Jun 11, 2025

Jun 11, 2025

Market news - investments.halifax.co.uk

Jun 11, 2025

Jun 11, 2025

MaxCyte enters collaboration with Ori Biotech - Sharecast.com

Jun 11, 2025

Jun 11, 2025

MaxCyte (MXCT) Partners with Ori Biotech to Boost Cell Therapy Manufacturing | MXCT Stock News - GuruFocus

Jun 11, 2025

Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing - Investing.com Australia

Jun 11, 2025